These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oxidative responses induced by pharmacologic vitreolysis and/or long-term hyperoxia treatment in rat lenses. Li Q; Yan H; Ding TB; Han J; Shui YB; Beebe DC Curr Eye Res; 2013 Jun; 38(6):639-48. PubMed ID: 23534693 [TBL] [Abstract][Full Text] [Related]
6. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes]. Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060 [TBL] [Abstract][Full Text] [Related]
7. Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator. Chen W; Huang X; Ma XW; Mo W; Wang WJ; Song HY Eye (Lond); 2008 Feb; 22(2):300-7. PubMed ID: 17704761 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacologic vitreolysis in diabetic rats]. Luo M; Wang ZL; Shi WD; Fan XQ; Xu GT Zhonghua Yan Ke Za Zhi; 2009 May; 45(5):417-23. PubMed ID: 19576064 [TBL] [Abstract][Full Text] [Related]
11. Effects of intravitreal dispase on vitreoretinal interface in rabbits. Zhu D; Chen H; Xu X Curr Eye Res; 2006 Nov; 31(11):935-46. PubMed ID: 17114119 [TBL] [Abstract][Full Text] [Related]
12. [Progression of pharmacologic vitreolysis research]. Zhou H; Ye J Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):225-9. PubMed ID: 24841819 [TBL] [Abstract][Full Text] [Related]
13. Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion. Murakami T; Takagi H; Ohashi H; Kita M; Nishiwaki H; Miyamoto K; Watanabe D; Sakamoto A; Yamaike N; Yoshimura N Retina; 2007 Oct; 27(8):1031-7. PubMed ID: 18040240 [TBL] [Abstract][Full Text] [Related]
14. Simulation of drug distribution in the vitreous body after local drug application into intact vitreous body and in progress of posterior vitreous detachment. Loch C; Bogdahn M; Stein S; Nagel S; Guthoff R; Weitschies W; Seidlitz A J Pharm Sci; 2014 Feb; 103(2):517-26. PubMed ID: 24311438 [TBL] [Abstract][Full Text] [Related]
15. [Posterior vitreous detachment induced by intravitreal injection of the combination of chondroitinase ABC and matrix metalloproteinase-3]. Meng ZJ; Zeng SQ Zhonghua Yan Ke Za Zhi; 2004 Sep; 40(9):625-31. PubMed ID: 15500769 [TBL] [Abstract][Full Text] [Related]
16. The vitreous, the retinal interface in ocular health and disease. de Smet MD; Gad Elkareem AM; Zwinderman AH Ophthalmologica; 2013; 230(4):165-78. PubMed ID: 23989078 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic vitreolysis--premise and promise of the first decade. Sebag J Retina; 2009; 29(7):871-4. PubMed ID: 19584647 [No Abstract] [Full Text] [Related]
18. Molecular biology of pharmacologic vitreolysis. Sebag J Trans Am Ophthalmol Soc; 2005; 103():473-94. PubMed ID: 17057814 [TBL] [Abstract][Full Text] [Related]
19. Relationship between vitreous temperature and posterior vitreous detachment. Chen K; Weiland JD J Mech Behav Biomed Mater; 2013 Oct; 26():54-8. PubMed ID: 23816597 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Hikichi T; Kado M; Yoshida A Retina; 2000; 20(2):195-8. PubMed ID: 10783954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]